December 15, 2025 · Form 4 insider transaction
Walker Karen Marie sold 23,998 shares of Kyverna Therapeutics, Inc. at $12.20 per share, a transaction worth $292.8K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
The transactions reported in this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 12, 2025 in effect at the time of such transactions.